PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 53 filers reported holding PROQR THRAPEUTICS N V in Q4 2019. The put-call ratio across all filers is 1.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 200 | 0.0% | 0.00% | – |
| Q4 2022 | $1,000 | – | 200 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 200 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 200 | -99.6% | 0.00% | – |
| Q1 2022 | $51,000 | -88.7% | 56,273 | 0.0% | 0.00% | – |
| Q4 2021 | $451,000 | -7.6% | 56,273 | -3.4% | 0.00% | – |
| Q3 2021 | $488,000 | +31.2% | 58,273 | +5.4% | 0.00% | – |
| Q2 2021 | $372,000 | +3.0% | 55,273 | +1.2% | 0.00% | – |
| Q1 2021 | $361,000 | +63.3% | 54,608 | +3.8% | 0.00% | – |
| Q4 2020 | $221,000 | -13.3% | 52,608 | -1.0% | 0.00% | – |
| Q3 2020 | $255,000 | -35.1% | 53,158 | -17.8% | 0.00% | – |
| Q2 2020 | $393,000 | +362.4% | 64,658 | +319.8% | 0.00% | – |
| Q1 2020 | $85,000 | +400.0% | 15,402 | +782.1% | 0.00% | – |
| Q4 2019 | $17,000 | +325.0% | 1,746 | +132.8% | 0.00% | – |
| Q3 2019 | $4,000 | +100.0% | 750 | +275.0% | 0.00% | – |
| Q2 2019 | $2,000 | -33.3% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | +300.0% | 200 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -66.7% | 200 | -72.3% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 723 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | -25.0% | 723 | 0.0% | 0.00% | – |
| Q3 2017 | $4,000 | +33.3% | 723 | +38.2% | 0.00% | – |
| Q2 2017 | $3,000 | 0.0% | 523 | 0.0% | 0.00% | – |
| Q1 2017 | $3,000 | 0.0% | 523 | 0.0% | 0.00% | – |
| Q4 2016 | $3,000 | 0.0% | 523 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 523 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -76.9% | 523 | -79.3% | 0.00% | – |
| Q1 2016 | $13,000 | +160.0% | 2,523 | +382.4% | 0.00% | – |
| Q4 2015 | $5,000 | -37.5% | 523 | 0.0% | 0.00% | – |
| Q3 2015 | $8,000 | -11.1% | 523 | 0.0% | 0.00% | – |
| Q2 2015 | $9,000 | -18.2% | 523 | -0.2% | 0.00% | – |
| Q1 2015 | $11,000 | – | 524 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
| Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
| DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
| Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
| EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
| Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
| UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |